← All Signals

🏥 FDA: K.C. Pharmaceuticals, Inc — Class II

healthcareactionableSource: FDA
85%Confidence
0Views
FDASource
2026-04-15Date

Summary

Sterility issues with tetrahydrozoline eye drops from K.C. Pharmaceuticals now affect Walgreens and Perrigo brands. This pattern suggests systemic manufacturing problems that could lead to broader regulatory action against the company.

Actionable: Contact Walgreens and Perrigo regarding their contingency plans for these eye drop products.

AI Confidence: 85%

Data Points

firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productSterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15mL) bottles; a) Good Sense Sterile Eye Drops, Distributed By: Perrigo Di

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now